Does change in language change the properties of a shortened score previously validated in its complete version? Validation of the French versions of the HOOS-12 and KOOS-12 scores in primary knee and hip arthroplasties.


Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
05 2021
Historique:
received: 21 01 2020
revised: 20 03 2020
accepted: 24 03 2020
pubmed: 26 1 2021
medline: 25 6 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

The HOOS and KOOS scoring questionnaires comprise respectively 40 and 42 items; a shorter 12-item version was recently developed, but remains to be validated in a French-speaking population. We therefore conducted a prospective study: 1) to determine whether the new 12-item versions in French are equivalent to the longer HOOS and KOOS versions, and 2) to validate the French-language HOOS-12 and KOOS-12 patient-reported outcome measures in a population of primary total hip and knee arthroplasty: validity, reliability, and responsiveness. The change in language in a score already validated in its long version does not alter its properties in the short version. One hundred patients (59 males, 41 females) undergoing primary total hip arthroplasty and 100 patients (43 males, 57 females) undergoing primary total knee arthroplasty were prospectively included. They filled out the original HOOS or KOOS questionnaires, their simplified versions (PS: Physical function Short form; JR: Joint Replacement) and the short HOOS-12 and KOOS-12 versions, and also the Oxford-12 score assessing the affected joint, preoperatively, then at 6-12 months. The 100% response rate confirmed ease of use. There were no redundant items. There were strong correlations between the 12-item and longer versions (>0.9). The HOOS-12 and KOOS-12 scores were reliable and valid: 1) there were no ceiling or floor effects for pre- or postoperative KOOS-12 scores, although a ceiling effect was found for HOOS-12 postoperatively (20% of patients having maximum scores of 100); 2) internal consistency was confirmed, with Cronbach alpha>0.8; 3) external consistency between Oxford-12 and HOOS-12/KOOS-12 was excellent, with Pearson correlation coefficient>0.8. Sensitivity to pre-/postoperative change was confirmed, with effect size>0.8. The present study confirmed the usefulness of this new 12-item form for HOOS and KOOS. Properties were identical between the French- and English-language versions, authorising everyday use of these simpler versions. IV; prospective study without control group.

Sections du résumé

BACKGROUND
The HOOS and KOOS scoring questionnaires comprise respectively 40 and 42 items; a shorter 12-item version was recently developed, but remains to be validated in a French-speaking population. We therefore conducted a prospective study: 1) to determine whether the new 12-item versions in French are equivalent to the longer HOOS and KOOS versions, and 2) to validate the French-language HOOS-12 and KOOS-12 patient-reported outcome measures in a population of primary total hip and knee arthroplasty: validity, reliability, and responsiveness.
HYPOTHESIS
The change in language in a score already validated in its long version does not alter its properties in the short version.
MATERIAL AND METHODS
One hundred patients (59 males, 41 females) undergoing primary total hip arthroplasty and 100 patients (43 males, 57 females) undergoing primary total knee arthroplasty were prospectively included. They filled out the original HOOS or KOOS questionnaires, their simplified versions (PS: Physical function Short form; JR: Joint Replacement) and the short HOOS-12 and KOOS-12 versions, and also the Oxford-12 score assessing the affected joint, preoperatively, then at 6-12 months.
RESULTS
The 100% response rate confirmed ease of use. There were no redundant items. There were strong correlations between the 12-item and longer versions (>0.9). The HOOS-12 and KOOS-12 scores were reliable and valid: 1) there were no ceiling or floor effects for pre- or postoperative KOOS-12 scores, although a ceiling effect was found for HOOS-12 postoperatively (20% of patients having maximum scores of 100); 2) internal consistency was confirmed, with Cronbach alpha>0.8; 3) external consistency between Oxford-12 and HOOS-12/KOOS-12 was excellent, with Pearson correlation coefficient>0.8. Sensitivity to pre-/postoperative change was confirmed, with effect size>0.8.
DISCUSSION
The present study confirmed the usefulness of this new 12-item form for HOOS and KOOS. Properties were identical between the French- and English-language versions, authorising everyday use of these simpler versions.
LEVEL OF EVIDENCE
IV; prospective study without control group.

Identifiants

pubmed: 33493653
pii: S1877-0568(21)00036-0
doi: 10.1016/j.otsr.2021.102824
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102824

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Sophie Putman (S)

Université de Lille, CHU de Lille, ULR 4490, Hôpital Salengro, 59000 Lille, France; Département universitaire de chirurgie orthopédique et traumatologique, hôpital Roger-Salengro, CHU de Lille, place de Verdun, 59037 Lille, France; Université de Lille, CHU de Lille, EA 2694-Metrics: évaluation des technologies de santé et des pratiques médicales, 59000 Lille, France. Electronic address: sophie.putman@wanadoo.fr.

Henri Migaud (H)

Université de Lille, CHU de Lille, ULR 4490, Hôpital Salengro, 59000 Lille, France; Département universitaire de chirurgie orthopédique et traumatologique, hôpital Roger-Salengro, CHU de Lille, place de Verdun, 59037 Lille, France.

Gilles Pasquier (G)

Université de Lille, CHU de Lille, ULR 4490, Hôpital Salengro, 59000 Lille, France; Département universitaire de chirurgie orthopédique et traumatologique, hôpital Roger-Salengro, CHU de Lille, place de Verdun, 59037 Lille, France.

Julien Girard (J)

Université de Lille, CHU de Lille, ULR 4490, Hôpital Salengro, 59000 Lille, France; Département universitaire de chirurgie orthopédique et traumatologique, hôpital Roger-Salengro, CHU de Lille, place de Verdun, 59037 Lille, France.

Cristian Preda (C)

Laboratory of mathematics Paul-Pain-Levé, UMR CNRS 8524, University of Lille, Lille, France; Lille catholic hospitals, Biostatistics department delegation for clinical research and innovation, Lille Catholic University, Lille, France.

Alain Duhamel (A)

Université de Lille, CHU de Lille, EA 2694-Metrics: évaluation des technologies de santé et des pratiques médicales, 59000 Lille, France; CHU de Lille, unité de methodologie et biostatistiques, 59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH